|
Volumn 237, Issue 2, 2005, Pages 381-382
|
Science to practice: Can combination therapy for colorectal liver metastases improve results over chemoembolization or ablation alone?
|
Author keywords
[No Author keywords available]
|
Indexed keywords
BEVACIZUMAB;
CETUXIMAB;
IODINATED POPPYSEED OIL;
MITOMYCIN C;
CANCER CHEMOTHERAPY;
CANCER SURGERY;
CANCER SURVIVAL;
CATHETER ABLATION;
CHEMOEMBOLIZATION;
CLINICAL TRIAL;
COLORECTAL CANCER;
HUMAN;
LIVER METASTASIS;
LOCAL THERAPY;
NONHUMAN;
NUCLEAR MAGNETIC RESONANCE IMAGING;
PRIORITY JOURNAL;
SHORT SURVEY;
TREATMENT INDICATION;
TREATMENT OUTCOME;
TUMOR VOLUME;
ANIMALS;
ANTIBIOTICS, ANTINEOPLASTIC;
CHEMOEMBOLIZATION, THERAPEUTIC;
COLORECTAL NEOPLASMS;
COMBINED MODALITY THERAPY;
IODIZED OIL;
LASERS;
LIVER NEOPLASMS;
MAGNETIC RESONANCE IMAGING;
MITOMYCIN;
RATS;
|
EID: 27144519125
PISSN: 00338419
EISSN: None
Source Type: Journal
DOI: 10.1148/radiol.2372050845 Document Type: Short Survey |
Times cited : (3)
|
References (7)
|